BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15571493)

  • 1. The C-terminal domain of the HIV-1 regulatory protein Vpr adopts an antiparallel dimeric structure in solution via its leucine-zipper-like domain.
    Bourbigot S; Beltz H; Denis J; Morellet N; Roques BP; Mély Y; Bouaziz S
    Biochem J; 2005 Apr; 387(Pt 2):333-41. PubMed ID: 15571493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: molecular insights into its biological functions.
    Schüler W; Wecker K; de Rocquigny H; Baudat Y; Sire J; Roques BP
    J Mol Biol; 1999 Feb; 285(5):2105-17. PubMed ID: 9925788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A carboxy-terminally truncated form of the Vpr protein of human immunodeficiency virus type 1 retards cell proliferation independently of G(2) arrest of the cell cycle.
    Nishizawa M; Myojin T; Nishino Y; Nakai Y; Kamata M; Aida Y
    Virology; 1999 Oct; 263(2):313-22. PubMed ID: 10544105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptosis by the Vpr protein of human immunodeficiency virus type 1 occurs independently of G(2) arrest of the cell cycle.
    Nishizawa M; Kamata M; Mojin T; Nakai Y; Aida Y
    Virology; 2000 Oct; 276(1):16-26. PubMed ID: 11021990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a leucine-zipper-like domain in Vpr protein of human immunodeficiency virus type 1.
    Wang L; Mukherjee S; Narayan O; Zhao LJ
    Gene; 1996 Oct; 178(1-2):7-13. PubMed ID: 8921884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).
    Gleenberg IO; Herschhorn A; Hizi A
    J Mol Biol; 2007 Jun; 369(5):1230-43. PubMed ID: 17490682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication.
    Thotala D; Schafer EA; Tungaturthi PK; Majumder B; Janket ML; Wagner M; Srinivasan A; Watkins S; Ayyavoo V
    Virology; 2004 Oct; 328(1):89-100. PubMed ID: 15380361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of apoptosis induced by HIV-1 Vpr and examination of the possible role of the hHR23A protein.
    Gaynor EM; Chen IS
    Exp Cell Res; 2001 Jul; 267(2):243-57. PubMed ID: 11426943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct Vpr-Vpr interaction in cells monitored by two photon fluorescence correlation spectroscopy and fluorescence lifetime imaging.
    Fritz JV; Didier P; Clamme JP; Schaub E; Muriaux D; Cabanne C; Morellet N; Bouaziz S; Darlix JL; Mély Y; de Rocquigny H
    Retrovirology; 2008 Sep; 5():87. PubMed ID: 18808682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residues within the HFRIGC sequence of HIV-1 vpr involved in growth arrest activities.
    Berglez JM; Castelli LA; Sankovich SA; Smith SC; Curtain CC; Macreadie IG
    Biochem Biophys Res Commun; 1999 Oct; 264(1):287-90. PubMed ID: 10527879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C.
    West MJ; Webb HM; Sinclair AJ; Woolfson DN
    J Virol; 2004 Sep; 78(17):9431-45. PubMed ID: 15308737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gelsolin segment 5 inhibits HIV-induced T-cell apoptosis via Vpr-binding to VDAC.
    Qiao H; McMillan JR
    FEBS Lett; 2007 Feb; 581(3):535-40. PubMed ID: 17254575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural studies of synthetic peptide fragments derived from the HIV-1 Vpr protein.
    Luo Z; Butcher DJ; Murali R; Srinivasan A; Huang Z
    Biochem Biophys Res Commun; 1998 Mar; 244(3):732-6. PubMed ID: 9535734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between the HIV-1 protein Vpr and the adenine nucleotide translocator.
    Sabbah EN; Druillennec S; Morellet N; Bouaziz S; Kroemer G; Roques BP
    Chem Biol Drug Des; 2006 Feb; 67(2):145-54. PubMed ID: 16492162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. His-Trp cation-π interaction and its structural role in an α-helical dimer of HIV-1 Vpr protein.
    Kamiyama T; Miura T; Takeuchi H
    Biophys Chem; 2013; 173-174():8-14. PubMed ID: 23467037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest.
    Henklein P; Bruns K; Sherman MP; Tessmer U; Licha K; Kopp J; de Noronha CM; Greene WC; Wray V; Schubert U
    J Biol Chem; 2000 Oct; 275(41):32016-26. PubMed ID: 10903315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophage Mu C protein is a new member of unusual leucine zipper-HTH class of proteins.
    Chakraborty A; Paul BD; Nagaraja V
    Protein Eng Des Sel; 2007 Jan; 20(1):1-5. PubMed ID: 17218337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR structure of the (1-51) N-terminal domain of the HIV-1 regulatory protein Vpr.
    Wecker K; Roques BP
    Eur J Biochem; 1999 Dec; 266(2):359-69. PubMed ID: 10561576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural characterization of the HIV-1 Vpr N terminus: evidence of cis/trans-proline isomerism.
    Bruns K; Fossen T; Wray V; Henklein P; Tessmer U; Schubert U
    J Biol Chem; 2003 Oct; 278(44):43188-201. PubMed ID: 12881523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway.
    Yoshizuka N; Yoshizuka-Chadani Y; Krishnan V; Zeichner SL
    J Virol; 2005 Sep; 79(17):11366-81. PubMed ID: 16103188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.